Entera Bio Ltd.
ENTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001638097
No open-market purchases or sales by Entera Bio Ltd. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $19.0M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Entera Bio Ltd. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 22 | 1 | 22 | +1 |
| Shares | 9.19M | 4.67K | 9.34M | +152.9K (+1.7%) |
| Value | $17.7M | $8.97K | $18.1M | +$480.9K (+2.7%) |
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (5)
Institutions that held Entera Bio Ltd. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Seven Fleet Capital Management LP | 135,318 | $262.5K | 0.18% |
| Gem Investment Advisors, LLC | 19,135 | $37.1K | 0.04% |
| Superstring Capital Management LP | 17,142 | $33.3K | 0.02% |
| Goldman Sachs Group Inc | 12,327 | $23.9K | 0.00% |
| Gsa Capital Partners LLP | 11,890 | $23.0K | 0.00% |
Sold out (4)
Institutions that held Entera Bio Ltd. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Bessemer Group Inc | 140,843 | $270.0K |
| XTX Topco Ltd | 10,771 | $20.7K |
| SBI Securities Co., Ltd. | 1 | $2 |
| Simplex Trading, LLC | 69 | $0 |
Not filed for Q4 2025 yet (1)
Institutions that held Entera Bio Ltd. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Cubist Systematic Strategies, LLC | 4,673 | $8.97K |